A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of Acinetobacter ursingii

[1] Peleg AY(2008)Acinetobacter baumannii: emergence of a successful pathogen Clin Microbiol Rev 21 538-82

[2] Seifert H(2003)Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative gram-negative rods Manual of clinical microbiology 8 749-79

[3] Paterson DL(1997)Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods J Clin Microbiol 35 2819-25

[4] Schreckenberger PC(1997)Impact of Acinetobacter spp. in intensive care units in Great Britain and Ireland J Hosp Infect 37 281-6

[5] Daneshvar MI(2009)Molecular characterization of carbapenem resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3 J Med Microbiol 58 209-16

[6] Weyant RS(2011)Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway J Antimicrob Chemother 66 738-44

[7] Hollis DG(2010)Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species J Clin Microbiol 48 1445-9

[8] Seifert H(2011)Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia Clin Infect Dis 52 352-60

[9] Dijkshoorn L(2013)Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5‐year period 2005–2009 Clin Microbiol Infect 19 737-42

[10] Gerner-Smidt P(2012)Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States J Infect 64 282-90

[1] Peleg AY(2008)Acinetobacter baumannii: emergence of a successful pathogen Clin Microbiol Rev 21 538-82

[2] Seifert H(2003)Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative gram-negative rods Manual of clinical microbiology 8 749-79

[3] Paterson DL(1997)Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods J Clin Microbiol 35 2819-25

[4] Schreckenberger PC(1997)Impact of Acinetobacter spp. in intensive care units in Great Britain and Ireland J Hosp Infect 37 281-6

[5] Daneshvar MI(2009)Molecular characterization of carbapenem resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3 J Med Microbiol 58 209-16

[6] Weyant RS(2011)Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway J Antimicrob Chemother 66 738-44

[7] Hollis DG(2010)Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species J Clin Microbiol 48 1445-9

[8] Seifert H(2011)Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia Clin Infect Dis 52 352-60

[9] Dijkshoorn L(2013)Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5‐year period 2005–2009 Clin Microbiol Infect 19 737-42

[10] Gerner-Smidt P(2012)Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States J Infect 64 282-90